Financial analysis of Rapid Micro Biosystems (NASDAQ:RPID) and HORIBA (OTCMKTS:HRIBF)

Rapid Micro Biosystems (NASDAQ:RPID – Get Rating) and HORIBA (OTCMKTS:HRIBF – Get Rating) are both medical companies, but which is the better stock? We’ll compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, institutional ownership, risk and dividends.

Institutional and Insider Ownership

69.8% of Rapid Micro Biosystems shares are held by institutional investors. 38.0% of the shares of Rapid Micro Biosystems are held by insiders. Strong institutional ownership indicates that endowments, hedge funds, and large money managers believe a stock is poised for long-term growth.


This table compares the net margins, return on equity and return on assets of Rapid Micro Biosystems and HORIBA.

Net margins Return on equity return on assets
Rapid microbiosystems -296.26% -44.23% -25.78%
HORIBA N / A N / A N / A

Analyst Notes

This is a summary of current ratings and target prices for Rapid Micro Biosystems and HORIBA, as reported by MarketBeat.

Sales Ratings Hold odds Buy reviews Strong buy odds Rating
Rapid microbiosystems 0 1 3 0 2.75
HORIBA 0 0 0 0 N / A

Rapid Micro Biosystems currently has a consensus price target of $22.67, indicating a potential upside of 435.86%. Considering the likely higher upside of Rapid Micro Biosystems, research analysts clearly believe that Rapid Micro Biosystems is more favorable than HORIBA.

Benefits and evaluation

This table compares the gross revenue, earnings per share and valuation of Rapid Micro Biosystems and HORIBA.

Gross revenue Price/sales ratio Net revenue Earnings per share Price/earnings ratio
Rapid microbiosystems $23.23 million 7.69 -73.52 million dollars ($21.42) -0.20
HORIBA $1.84 billion 1.15 N / A N / A N / A

HORIBA has higher revenues and profits than Rapid Micro Biosystems.


Rapid Micro Biosystems beats HORIBA on 5 of the 9 factors compared between the two stocks.

About Rapid Micro Biosystems (Get an evaluation)

Rapid Micro Biosystems, Inc., a life science technology company, provides products for the detection of microbial contamination in the manufacturing of pharmaceutical, medical and personal care products in North America, Europe and Asia. The company offers the Growth Direct platform, which includes the Growth Direct system, proprietary consumables, laboratory information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides installation and verification services, technical training and support. Its solutions are used in environmental monitoring, water analysis, bioburden and sterility release applications. The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.

About HORIBA (Get an evaluation)

HORIBA, Ltd. manufactures and sells instruments and systems for various applications. It operates in five segments: automotive, process and environment, medical diagnostics, semiconductor and scientific. The Automotive segment offers automotive emissions analyzers, emissions measurement systems, transmission test systems, engine and fuel cell test systems, and battery test systems; test systems for engines, chassis, powertrains, brakes and catalysts; and vehicle development and testing engineering services, as well as rental and management of R&D facilities. The Process & Environmental segment provides stack gas analyzers, industrial water quality analyzers, water quality analysis and review systems, air pollution analyzers, environmental radiation and process measurement equipment. The Medical-Diagnostics segment offers hematology and CRP, immunology, clinical chemistry and blood glucose analyzers. The Semiconductor Instruments & Systems segment provides mass flow controllers, chemical concentration monitors, reticle/mask particle detection systems, residual gas analyzers and vaporizers. The Scientific segment offers Raman spectrometers, pH meters, particle size distribution analyzers, X-ray fluorescence analyzers, elemental analyzers, fluorescence spectroscopy/fluorescence lifetime spectroscopy, optical components, spectrometers and detectors , and networks. The company was founded in 1945 and is based in Kyoto, Japan.

Get news and reviews for Rapid Micro Biosystems Daily – Enter your email address below to receive a concise daily summary of the latest news and analyst ratings for Rapid Micro Biosystems and related companies with’s free daily email newsletter.

Sarah J. Greer